结果页面 2，板块：医疗保健，行业：药品制造商 – 仿制药，股市 - 报价与价格
包含价格、市值、市盈率和每股收益的所有股票清单
所有国家
所有交流
- {{item.name}}
- 所有交流
- ASX (1)
- BSE (10)
- Budapest (1)
- Buenos Aires (12)
- Canadian Sec (1)
- Cboe CA (1)
- Frankfurt (44)
- Helsinki (2)
- HKSE (1)
- IOB (16)
- Istanbul (1)
- KSE (3)
- Mexico (14)
- Milan (5)
- Munich (1)
- NSE (8)
- NYSE (6)
- OTC Markets OTCPK (28)
- OTC Markets OTCQX (4)
- Paris (2)
- Santiago (4)
- São Paulo (14)
- SES (1)
- Shanghai (4)
- Shenzhen (4)
- Stockholm (3)
- Swiss (5)
- Taipei Exchange (1)
- Tech Market Large (4)
- Tech Market Middle (1)
- Tech Market Small (1)
- Tokyo (7)
- Vienna (13)
- XETRA (12)
医疗保健 (243)
- {{item.name}}
- 所有版块
- 医疗保健 (243)
药品制造商 – 仿制药 (243)
| 名称 名称 | 价格 价格 |
24h% 7d chart 24h% & 7d |
市值 市值 | 交易量 交易量 | 低24小时 | 高24小时 | 市值 | 市盈率 | 每股收益 |
|---|
| 名称 名称 | 价格 价格 |
24h% 7d chart 24h% & 7d |
市值 市值 | 交易量 交易量 | 低24小时 | 高24小时 | 市值 | 市盈率 | 每股收益 | |
|---|---|---|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.marketcap }} {{ item.marketcap_usd }} | {{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.marketcap }} {{ item.marketcap_usd }} | {{ item.pe }} | {{ item.eps }} {{ item.eps_usd }} | |
| Novartis AG N1VS34.SA | R$67.76 13.73 USD |
+0.1
|
R$1.30T 263.61B USD | R$0.00 0 USD | R$0.00 0 USD | R$0.00 0 USD | R$1.30T 263.61B USD | 17.32 | R$3.91 0.79 USD | |
| AstraZeneca PLC ZEG.F | €149.35 163.26 USD |
+2.33
|
€231.53B 253.1B USD | €185.00 202.23 USD | €146.30 159.93 USD | €149.35 163.26 USD | €231.53B 253.1B USD | 28.66 | €5.21 5.7 USD | |
| Roche Holding AG RHO6.F | €36.45 39.84 USD |
+3.02
|
€230.51B 251.97B USD | €20.00 21.86 USD | €36.45 39.84 USD | €36.45 39.84 USD | €230.51B 251.97B USD | 23.21 | €1.57 1.72 USD | |
| Gilead Sciences, Inc. GILD.BA | ARS 43,580.00 51.51 USD |
-0.41
|
ARS 213.02T 251.8B USD | ARS 269.00 0.32 USD | ARS 43,220.00 51.09 USD | ARS 43,780.00 51.75 USD | ARS 213.02T 251.8B USD | 4.64 | ARS 9.37K 11.08 USD | |
| AstraZeneca PLC ZEGA.F | €72.50 79.25 USD |
+1.4
|
€224.79B 245.73B USD | €410.00 448.19 USD | €72.50 79.25 USD | €72.50 79.25 USD | €224.79B 245.73B USD | 27.77 | €2.61 2.85 USD | |
| Merck & Co., Inc. MRK.SN | $89.12 — |
+12.61
|
$241.15B — | $0.00 — | $89.12 — | $89.12 — | $241.15B — | 11.78 | $7.56 — | |
| Pfizer Inc. PFE.BA | ARS 8,980.00 10.61 USD |
-0.06
|
ARS 201.40T 238.06B USD | ARS 86.17K 101.86 USD | ARS 8,800.00 10.4 USD | ARS 9,145.00 10.81 USD | ARS 201.40T 238.06B USD | 1.79 | ARS 4.99K 5.9 USD | |
| Merck & Co., Inc. MRK.MX | MX$1,596.99 94.56 USD |
+0.19
|
MX$3.99T 236.12B USD | MX$334.00 19.78 USD | MX$1,582.00 93.67 USD | MX$1,600.00 94.74 USD | MX$3.99T 236.12B USD | 11.35 | MX$140.59 8.32 USD | |
| Merck & Co., Inc. MRCK34.SA | R$57.36 11.63 USD |
+0.02
|
R$1.15T 232.36B USD | R$0.00 0 USD | R$0.00 0 USD | R$0.00 0 USD | R$1.15T 232.36B USD | 11.33 | R$5.06 1.03 USD | |
| Novartis AG NOTA.F | €110.50 120.79 USD |
+2.79
|
€212.03B 231.77B USD | €2.00 2.19 USD | €107.50 117.51 USD | €110.50 120.79 USD | €212.03B 231.77B USD | 17.45 | €6.33 6.92 USD | |
| Merck & Co., Inc. 6MK.DE | €74.50 81.44 USD |
+0.13
|
€186.35B 203.7B USD | €4.11K 4.49K USD | €74.50 81.44 USD | €75.30 82.31 USD | €186.35B 203.7B USD | 11.39 | €6.54 7.15 USD | |
| Merck & Co., Inc. MRK.VI | €74.40 81.33 USD |
-0.27
|
€185.60B 202.88B USD | €492.00 537.82 USD | €74.40 81.33 USD | €75.00 81.99 USD | €185.60B 202.88B USD | 11.34 | €6.56 7.17 USD | |
| Merck & Co., Inc. 6MK.F | €74.40 81.33 USD |
-0.27
|
€185.10B 202.34B USD | €2.23K 2.43K USD | €74.40 81.33 USD | €75.30 82.31 USD | €185.10B 202.34B USD | 11.35 | €6.55 7.16 USD | |
| Amgen Inc. AMGN.MX | MX$5,990.00 354.68 USD |
0
|
MX$3.23T 190.99B USD | MX$0.00 0 USD | MX$0.00 0 USD | MX$0.00 0 USD | MX$3.23T 190.99B USD | 24.93 | MX$240.20 14.22 USD | |
| Amgen Inc. AMGN34.SA | R$61.09 12.38 USD |
+1.26
|
R$934.51B 189.41B USD | R$0.00 0 USD | R$0.00 0 USD | R$0.00 0 USD | R$934.51B 189.41B USD | 24.73 | R$2.47 0.5 USD | |
| Gilead Sciences, Inc. GILD.MX | MX$2,287.97 135.48 USD |
0
|
MX$2.84T 168.26B USD | MX$0.00 0 USD | MX$0.00 0 USD | MX$0.00 0 USD | MX$2.84T 168.26B USD | 19.04 | MX$120.12 7.11 USD | |
| GSK plc GSK.BA | ARS 17,510.00 20.7 USD |
+2.34
|
ARS 140.74T 166.36B USD | ARS 276.00 0.33 USD | ARS 17,030.00 20.13 USD | ARS 17,510.00 20.7 USD | ARS 140.74T 166.36B USD | 13.81 | ARS 1.27K 1.5 USD | |
| Bristol-Myers Squibb Company BMY.BA | ARS 23,280.00 27.52 USD |
+1.48
|
ARS 139.94T 165.41B USD | ARS 1.83K 2.16 USD | ARS 22,880.00 27.04 USD | ARS 23,300.00 27.54 USD | ARS 139.94T 165.41B USD | 5.40 | ARS 4.31K 5.09 USD | |
| Amgen Inc. AMG.F | €279.15 305.15 USD |
+1.51
|
€150.32B 164.32B USD | €100.00 109.31 USD | €279.15 305.15 USD | €279.20 305.2 USD | €150.32B 164.32B USD | 24.94 | €11.19 12.23 USD | |
| Amgen Inc. AMGN.VI | €276.85 302.63 USD |
-0.22
|
€149.08B 162.96B USD | €310.00 338.87 USD | €275.10 300.72 USD | €277.55 303.4 USD | €149.08B 162.96B USD | 24.69 | €11.21 12.25 USD | |
| Amgen Inc. AMG.DE | €276.75 302.53 USD |
-0.22
|
€149.02B 162.9B USD | €1.27K 1.39K USD | €273.50 298.97 USD | €281.10 307.28 USD | €149.02B 162.9B USD | 24.68 | €11.21 12.25 USD | |
| Gilead Sciences, Inc. GILD34.SA | R$318.17 64.49 USD |
-3.4
|
R$790.33B 160.19B USD | R$0.00 0 USD | R$0.00 0 USD | R$0.00 0 USD | R$790.33B 160.19B USD | 18.40 | R$17.29 3.5 USD | |
| Pfizer Inc. PFE.SN | $27.75 — |
+6.49
|
$157.78B — | $0.00 — | $27.75 — | $27.75 — | $157.78B — | 16.13 | $1.72 — | |
| Amgen Inc. 0R0T.IL | $287.63 — |
+0.57
|
$157.63B — | $1.00 — | $0.00 — | $0.00 — | $157.63B — | 19.38 | $14.84 — | |
| Pfizer Inc. PFE.MX | MX$449.63 26.62 USD |
-0.08
|
MX$2.58T 152.74B USD | MX$761.00 45.06 USD | MX$441.50 26.14 USD | MX$453.61 26.86 USD | MX$2.58T 152.74B USD | 14.07 | MX$31.95 1.89 USD | |
| Pfizer Inc. PFIZ34.SA | R$32.35 6.56 USD |
-0.06
|
R$743.01B 150.6B USD | R$0.00 0 USD | R$0.00 0 USD | R$0.00 0 USD | R$743.01B 150.6B USD | 14.06 | R$2.30 0.47 USD | |
| Gilead Sciences, Inc. GILD.SN | $110.29 — |
-0.13
|
$147.26B — | $0.00 — | $110.29 — | $110.29 — | $147.26B — | 17.07 | $6.46 — | |
| Pfizer Inc. PFEB.F | €7.20 7.87 USD |
+9.09
|
€132.13B 144.43B USD | €50.00 54.66 USD | €6.60 7.21 USD | €7.20 7.87 USD | €132.13B 144.43B USD | 14.11 | €0.51 0.56 USD | |
| Gilead Sciences, Inc. GILD.VI | €101.74 111.22 USD |
-2.49
|
€128.57B 140.55B USD | €0.00 0 USD | €101.74 111.22 USD | €103.10 112.7 USD | €128.57B 140.55B USD | 18.20 | €5.59 6.11 USD | |
| Gilead Sciences, Inc. GIS.F | €102.14 111.65 USD |
-4.54
|
€126.72B 138.53B USD | €505.00 552.03 USD | €102.14 111.65 USD | €103.04 112.64 USD | €126.72B 138.53B USD | 18.23 | €5.60 6.12 USD | |
| Gilead Sciences, Inc. GIS.DE | €101.70 111.17 USD |
-2.46
|
€126.18B 137.93B USD | €1.95K 2.14K USD | €101.60 111.06 USD | €103.42 113.05 USD | €126.18B 137.93B USD | 18.16 | €5.60 6.12 USD | |
| Pfizer Inc. PFE.VI | €20.79 22.72 USD |
-1.26
|
€121.12B 132.4B USD | €2.28K 2.49K USD | €20.79 22.72 USD | €21.41 23.4 USD | €121.12B 132.4B USD | 14.04 | €1.48 1.62 USD | |
| Sanofi SNW2.F | €43.00 47 USD |
+1.42
|
€108.21B 118.28B USD | €20.00 21.86 USD | €42.40 46.35 USD | €43.00 47 USD | €108.21B 118.28B USD | 16.41 | €2.62 2.86 USD | |
| Sanofi SNW.F | €86.47 94.52 USD |
+1.23
|
€108.01B 118.07B USD | €1.07K 1.17K USD | €86.11 94.13 USD | €86.47 94.52 USD | €108.01B 118.07B USD | 16.50 | €5.24 5.73 USD | |
| Sanofi SANO.VI | €86.54 94.6 USD |
+1.2
|
€106.70B 116.63B USD | €102.00 111.5 USD | €85.86 93.86 USD | €86.60 94.67 USD | €106.70B 116.63B USD | 16.32 | €5.30 5.79 USD | |
| Bristol-Myers Squibb Company BMY.MX | MX$860.14 50.93 USD |
-0.79
|
MX$1.75T 103.78B USD | MX$506.00 29.96 USD | MX$860.14 50.93 USD | MX$867.00 51.34 USD | MX$1.75T 103.78B USD | 15.57 | MX$55.23 3.27 USD | |
| Bristol-Myers Squibb Company BMYB34.SA | R$250.25 50.72 USD |
0
|
R$509.45B 103.26B USD | R$0.00 0 USD | R$0.00 0 USD | R$0.00 0 USD | R$509.45B 103.26B USD | 15.74 | R$15.89 3.22 USD | |
| GSK plc GSKN.MX | MX$866.15 51.29 USD |
+0.05
|
MX$1.74T 103.06B USD | MX$0.00 0 USD | MX$0.00 0 USD | MX$0.00 0 USD | MX$1.74T 103.06B USD | 13.33 | MX$64.93 3.84 USD | |
| GSK plc G1SK34.SA | R$49.35 10 USD |
-1.4
|
R$495.82B 100.5B USD | R$0.00 0 USD | R$0.00 0 USD | R$0.00 0 USD | R$495.82B 100.5B USD | 13.19 | R$3.74 0.76 USD | |
| GSK GLAXF | $23.13 — |
+0.13
|
$93.38B — | $400.00 — | $23.13 — | $23.13 — | $93.38B — | 13.21 | $1.75 — | |
| Bristol-Myers Squibb Company BRM.F | €40.87 44.68 USD |
+1.28
|
€83.20B 90.95B USD | €1.03K 1.12K USD | €40.66 44.44 USD | €41.20 45.04 USD | €83.20B 90.95B USD | 15.90 | €2.57 2.81 USD | |
| Bristol-Myers Squibb Company BMYS.VI | €40.48 44.25 USD |
-0.01
|
€82.41B 90.08B USD | €0.00 0 USD | €40.40 44.16 USD | €40.61 44.39 USD | €82.41B 90.08B USD | 15.75 | €2.57 2.81 USD | |
| Bristol-Myers Squibb Company BRM.DE | €40.45 44.21 USD |
0
|
€82.34B 90B USD | €1.31K 1.43K USD | €40.36 44.11 USD | €40.61 44.39 USD | €82.34B 90B USD | 15.73 | €2.57 2.81 USD | |
| Chugai Pharmaceutical CHGCF | $45.50 — |
+0.95
|
$74.88B — | $100.00 — | $45.50 — | $45.50 — | $74.88B — | 28.98 | $1.57 — | |
| Chugai Pharmaceutical Co., Ltd. CUP.F | €40.40 44.16 USD |
-2.46
|
€66.49B 72.68B USD | €50.00 54.66 USD | €40.40 44.16 USD | €40.48 44.25 USD | €66.49B 72.68B USD | 30.37 | €1.33 1.45 USD | |
| Daiichi Sankyo Company, Limited D4S.F | €18.28 19.98 USD |
-2.77
|
€38.13B 41.68B USD | €350.00 382.6 USD | €18.28 19.98 USD | €18.28 19.98 USD | €38.13B 41.68B USD | 22.29 | €0.82 0.9 USD | |
| Biogen Inc. BIIB.BA | ARS 17,770.00 21 USD |
+1.78
|
ARS 33.68T 39.82B USD | ARS 1.28K 1.51 USD | ARS 17,460.00 20.64 USD | ARS 17,780.00 21.02 USD | ARS 33.68T 39.82B USD | 1.11 | ARS 15.91K 18.81 USD | |
| Bayer Aktiengesellschaft BAYZF | $31.05 — |
+1.67
|
$30.53B — | $2.46K — | $30.97 — | $31.76 — | $30.53B — | 0 | -$4.03 — | |
| Bayer Aktiengesellschaft BAYA.F | €6.45 7.05 USD |
+0.78
|
€26.68B 29.17B USD | €1.80K 1.97K USD | €6.45 7.05 USD | €6.45 7.05 USD | €26.68B 29.17B USD | 0 | -€0.87 -0.9 USD | |
| Bayer Aktiengesellschaft BAYN.VI | €26.47 28.94 USD |
+1.59
|
€26.48B 28.94B USD | €0.00 0 USD | €26.32 28.77 USD | €26.49 28.96 USD | €26.48B 28.94B USD | 0 | -€3.48 -3.8 USD | |
| Bayer Aktiengesellschaft BAYER.BD | HUF 10,100.00 27.93 USD |
-2.02
|
HUF 10.30T 28.49B USD | HUF 25.00 0.07 USD | HUF 10,100.00 27.93 USD | HUF 10,100.00 27.93 USD | HUF 10.30T 28.49B USD | 0 | -HUF 1,347.00 -3.7 USD | |
| Otsuka Holdings Co., Ltd. OS1.F | €45.60 49.85 USD |
-4.6
|
€24.83B 27.15B USD | €20.00 21.86 USD | €45.60 49.85 USD | €45.60 49.85 USD | €24.83B 27.15B USD | 11.09 | €4.11 4.49 USD | |
| Biogen Inc. BIIB.MX | MX$2,790.00 165.2 USD |
0
|
MX$424.02B 25.11B USD | MX$0.00 0 USD | MX$0.00 0 USD | MX$0.00 0 USD | MX$424.02B 25.11B USD | 13.67 | MX$203.95 12.08 USD | |
| Biogen Inc. BIIB34.SA | R$139.44 28.26 USD |
-0.5
|
R$123.23B 24.98B USD | R$0.00 0 USD | R$0.00 0 USD | R$0.00 0 USD | R$123.23B 24.98B USD | 14.30 | R$9.75 1.98 USD | |
| Biogen Inc. IDP.F | €135.00 147.57 USD |
+1.58
|
€19.87B 21.72B USD | €298.00 325.75 USD | €132.75 145.11 USD | €135.00 147.57 USD | €19.87B 21.72B USD | 14.21 | €9.50 10.38 USD | |
| Biogen Inc. IDP.DE | €134.10 146.59 USD |
+0.83
|
€19.67B 21.51B USD | €428.00 467.86 USD | €133.15 145.55 USD | €134.95 147.52 USD | €19.67B 21.51B USD | 14.10 | €9.51 10.4 USD | |
| Biogen Inc. BIIB.VI | €133.85 146.32 USD |
+0.68
|
€19.64B 21.46B USD | €0.00 0 USD | €133.85 146.32 USD | €135.10 147.68 USD | €19.64B 21.46B USD | 13.92 | €9.61 10.51 USD | |
| Astellas Pharma ALPMF | $10.80 — |
-1.82
|
$20.05B — | $100.00 — | $10.80 — | $10.80 — | $20.05B — | 24.00 | $0.45 — | |
| Astellas Pharma Inc. YPH.F | €9.72 10.63 USD |
+3.65
|
€17.41B 19.03B USD | €50.00 54.66 USD | €9.54 10.43 USD | €9.72 10.63 USD | €17.41B 19.03B USD | 23.70 | €0.41 0.45 USD | |
| Astellas Pharma Inc. YPHA.F | €9.50 10.38 USD |
-0.52
|
€17.02B 18.6B USD | €379.00 414.3 USD | €9.50 10.38 USD | €9.50 10.38 USD | €17.02B 18.6B USD | 24.35 | €0.39 0.43 USD | |
| Cipla Limited CIPLA.BO | ₹1,509.80 18.27 USD |
-0.26
|
₹1.22T 14.75B USD | ₹82.51K 998.23 USD | ₹1,505.70 18.22 USD | ₹1,517.45 18.36 USD | ₹1.22T 14.75B USD | 22.41 | ₹67.36 0.81 USD | |
| Recordati Industria Chimica e Farmaceutica S.p.A. REC.VI | €50.40 55.09 USD |
+1.53
|
€10.53B 11.51B USD | €0.00 0 USD | €50.05 54.71 USD | €50.45 55.15 USD | €10.53B 11.51B USD | 25.84 | €1.95 2.13 USD | |
| Recordati Industria Chimica e Farmaceutica S.p.A. RER1.F | €50.25 54.93 USD |
+1.52
|
€10.53B 11.51B USD | €55.00 60.12 USD | €49.72 54.35 USD | €50.25 54.93 USD | €10.53B 11.51B USD | 25.76 | €1.95 2.13 USD | |
| Orion Oyj ORINF | $81.30 — |
0
|
$11.16B — | $100.00 — | $81.30 — | $81.30 — | $11.16B — | 26.05 | $3.12 — | |
| CSPC Pharmaceutical Group Limited CVG.F | €0.83 0.9 USD |
+3.38
|
€10.05B 10.98B USD | €2.00K 2.19K USD | €0.83 0.9 USD | €0.83 0.9 USD | €10.05B 10.98B USD | 20.63 | €0.04 0.04 USD | |
| Orion Oyj ORINY | $34.18 — |
+9.73
|
$10.40B — | $2.00 — | $34.18 — | $34.18 — | $10.40B — | 26.49 | $1.29 — | |
| Orion Oyj OFK.F | €58.05 63.46 USD |
+1.31
|
€8.61B 9.41B USD | €24.00 26.24 USD | €57.50 62.86 USD | €58.05 63.46 USD | €8.61B 9.41B USD | 26.03 | €2.23 2.44 USD | |
| Orion Oyj OFK0.F | €28.60 31.26 USD |
0
|
€8.46B 9.25B USD | €500.00 546.57 USD | €28.60 31.26 USD | €28.60 31.26 USD | €8.46B 9.25B USD | 25.53 | €1.12 1.22 USD | |
| Grifols, S.A. GIKLY | $6.70 — |
-2.19
|
$8.32B — | $50.00 — | $6.70 — | $6.70 — | $8.32B — | 20.93 | $0.32 — | |
| Grifols GIFLF | $14.00 — |
+0.72
|
$8.31B — | $500.00 — | $14.00 — | $14.00 — | $8.31B — | 27.45 | $0.51 — | |
| Grifols, S.A. GIFOF | $8.25 — |
-6.41
|
$8.05B — | $4.41K — | $8.18 — | $8.25 — | $8.05B — | 15.86 | $0.52 — | |
| Grifols, S.A. G0FB.F | €7.55 8.25 USD |
+6.34
|
€7.25B 7.92B USD | €300.00 327.94 USD | €7.20 7.87 USD | €7.55 8.25 USD | €7.25B 7.92B USD | 13.72 | €0.55 0.6 USD | |
| Kyowa Kirin Co., Ltd. KY4.F | €13.50 14.76 USD |
0
|
€7.07B 7.73B USD | €15.00 16.4 USD | €13.40 14.65 USD | €13.50 14.76 USD | €7.07B 7.73B USD | 32.14 | €0.42 0.46 USD | |
| Abbott India Limited ABBOTINDIA.BO | ₹29,551.25 357.52 USD |
+0.19
|
₹627.94B 7.6B USD | ₹176.00 2.13 USD | ₹29,363.05 355.24 USD | ₹29,756.05 360 USD | ₹627.94B 7.6B USD | 41.57 | ₹710.87 8.6 USD | |
| Grifols, S.A. G0F.F | €4.96 5.42 USD |
+0.81
|
€6.87B 7.51B USD | €160.00 174.9 USD | €4.96 5.42 USD | €4.96 5.42 USD | €6.87B 7.51B USD | 18.37 | €0.27 0.3 USD | |
| Grifols, S.A. OZTA.F | €10.47 11.44 USD |
+0.72
|
€6.86B 7.5B USD | €74.00 80.89 USD | €10.47 11.44 USD | €10.47 11.44 USD | €6.86B 7.5B USD | 19.02 | €0.55 0.6 USD | |
| Grifols, S.A. GRF.VI | €10.47 11.45 USD |
+1.26
|
€6.81B 7.45B USD | €0.00 0 USD | €10.47 11.45 USD | €10.60 11.59 USD | €6.81B 7.45B USD | 19.03 | €0.55 0.6 USD | |
| Kyowa Kirin KYKOF | $13.58 — |
0
|
$7.11B — | $100.00 — | $13.58 — | $13.58 — | $7.11B — | 28.29 | $0.48 — | |
| Ono Pharmaceutical OPHLF | $12.22 — |
+0.16
|
$5.86B — | $104.00 — | $12.22 — | $12.22 — | $5.86B — | 16.73 | $0.73 — | |
| Ono Pharmaceutical Co., Ltd. ON4.F | €10.60 11.59 USD |
0
|
€4.98B 5.44B USD | €75.00 81.99 USD | €10.50 11.48 USD | €10.60 11.59 USD | €4.98B 5.44B USD | 16.82 | €0.63 0.69 USD | |
| Ono Pharmaceutical Co., Ltd. ON4.MU | €10.60 11.59 USD |
0
|
€4.98B 5.44B USD | €0.00 0 USD | €0.00 0 USD | €0.00 0 USD | €4.98B 5.44B USD | 16.82 | €0.63 0.69 USD | |
| GlaxoSmithKline Pharmaceuticals Limited GLAXO.BO | ₹2,492.00 30.15 USD |
-1.9
|
₹436.11B 5.28B USD | ₹3.58K 43.26 USD | ₹2,468.00 29.86 USD | ₹2,565.00 31.03 USD | ₹436.11B 5.28B USD | 44.19 | ₹56.39 0.68 USD | |
| GlaxoSmithKline Pharmaceuticals Limited GLAXO.NS | ₹2,484.80 30.06 USD |
-2.17
|
₹434.94B 5.26B USD | ₹205.34K 2.48K USD | ₹2,468.10 29.86 USD | ₹2,550.70 30.86 USD | ₹434.94B 5.26B USD | 44.07 | ₹56.38 0.68 USD | |
| Santen Pharmaceutical SNPHF | $12.64 — |
+25.02
|
$4.11B — | $200.00 — | $12.46 — | $12.64 — | $4.11B — | 21.06 | $0.60 — | |
| Gland Pharma Limited GLAND.NS | ₹1,866.00 22.58 USD |
-0.8
|
₹315.25B 3.81B USD | ₹10.72K 129.69 USD | ₹1,862.00 22.53 USD | ₹1,896.90 22.95 USD | ₹315.25B 3.81B USD | 38.89 | ₹47.97 0.58 USD | |
| Gland Pharma Limited GLAND.BO | ₹1,864.25 22.55 USD |
-0.92
|
₹314.88B 3.81B USD | ₹708.00 8.57 USD | ₹1,864.10 22.55 USD | ₹1,906.45 23.06 USD | ₹314.88B 3.81B USD | 38.85 | ₹47.98 0.58 USD | |
| Virbac SA V16.F | €346.50 378.77 USD |
+1.61
|
€3.05B 3.34B USD | €117.00 127.9 USD | €338.00 369.48 USD | €347.00 379.32 USD | €3.05B 3.34B USD | 21.80 | €15.89 17.37 USD | |
| Virbac SA VIRP.PA | €345.50 377.68 USD |
+0.14
|
€3.04B 3.32B USD | €1.48K 1.62K USD | €346.00 378.22 USD | €353.00 385.88 USD | €3.04B 3.32B USD | 21.77 | €15.87 17.35 USD | |
| Virbac SA 0NM7.IL | €346.00 378.22 USD |
+0.22
|
€2.95B 3.22B USD | €0.00 0 USD | €0.00 0 USD | €0.00 0 USD | €2.95B 3.22B USD | 24.73 | €13.99 15.29 USD | |
| Santen Pharmaceutical Co., Ltd. SZD.F | €8.35 9.13 USD |
0
|
€2.75B 3.01B USD | €23.00 25.14 USD | €8.35 9.13 USD | €8.35 9.13 USD | €2.75B 3.01B USD | 16.05 | €0.52 0.57 USD | |
| PT Kalbe Farma Tbk PTKFF | $0.06 — |
-21.95
|
$2.84B — | $4.00K — | $0.06 — | $0.06 — | $2.84B — | 0 | $0.00 — | |
| Pfizer Limited PFIZER.NS | ₹4,995.50 60.44 USD |
-2.81
|
₹231.60B 2.8B USD | ₹9.32K 112.76 USD | ₹4,982.50 60.28 USD | ₹5,144.50 62.24 USD | ₹231.60B 2.8B USD | 28.25 | ₹176.82 2.14 USD | |
| Pfizer Limited PFIZER.BO | ₹4,991.00 60.38 USD |
-3.02
|
₹231.11B 2.8B USD | ₹690.00 8.35 USD | ₹4,991.00 60.38 USD | ₹5,140.00 62.19 USD | ₹231.11B 2.8B USD | 28.27 | ₹176.51 2.14 USD | |
| Haw Par Corporation Limited HAWPY | $46.98 — |
-7.52
|
$2.60B — | $10.00 — | $46.98 — | $46.98 — | $2.60B — | 13.53 | $3.47 — | |
| Haw Par HAWPF | $10.62 — |
-5.43
|
$2.57B — | $100.00 — | $10.62 — | $10.62 — | $2.57B — | 12.20 | $0.87 — | |
| Organon & Co. OGN.MX | MX$138.00 8.17 USD |
+15
|
MX$37.67B 2.23B USD | MX$10.27K 607.81 USD | MX$126.20 7.47 USD | MX$138.00 8.17 USD | MX$37.67B 2.23B USD | 2.76 | MX$49.99 2.96 USD | |
| Organon & Co. 7XP.F | €6.69 7.31 USD |
+14.84
|
€1.74B 1.9B USD | €168.00 183.65 USD | €5.83 6.38 USD | €6.69 7.31 USD | €1.74B 1.9B USD | 2.86 | €2.33 2.55 USD | |
| Luye Pharma Group Ltd. LUP.F | €0.34 0.37 USD |
+1.8
|
€1.42B 1.55B USD | €20.00 21.86 USD | €0.34 0.37 USD | €0.34 0.37 USD | €1.42B 1.55B USD | 34.00 | €0.01 0.01 USD | |
| Sanofi India Limited SANOFI.BO | ₹4,584.00 55.46 USD |
-0.29
|
₹109.77B 1.33B USD | ₹260.00 3.15 USD | ₹4,575.50 55.36 USD | ₹4,608.55 55.76 USD | ₹109.77B 1.33B USD | 29.67 | ₹154.47 1.87 USD | |
| Sanofi India Limited SANOFI.NS | ₹4,583.10 55.45 USD |
-0.32
|
₹109.74B 1.33B USD | ₹4.84K 58.53 USD | ₹4,570.10 55.29 USD | ₹4,611.10 55.79 USD | ₹109.74B 1.33B USD | 29.66 | ₹154.48 1.87 USD | |
|
没有最喜欢的股票
您还没有喜欢的股票，请将其添加到收藏夹以在此处查看 |
||||||||||
- {{ link.label }} {{link}}